CA
NZ
UK
AU
IND
US
● No company-specific announcement explained the move.
● Monday's rally recovered part of that damage.
● The full-year forecast rose to $198.2 million to $200.7 million.
● Treace Medical is a medical device maker.
● Hold is not a call for the shares to outperform.
● The upgrade signals a less bearish view, not a bullish one.
● No company-specific news explained the move.
● Revenue of $736 million beat the $651.4 million estimate.
● Third-quarterRevenuewas $736 million versus $651.4 million expected.
● No company-specific news explained the move.
Please wait processing your request...